Regulations.gov document
Final Response from FDA CDER to Baker & Hostetler LLP (Salix Pharmaceuticals, Inc.)
Other · FDA-2016-P-3418 · posted Mar 16, 2017
Key facts
| Document ID | FDA-2016-P-3418-0120 |
|---|---|
| Title | Final Response from FDA CDER to Baker & Hostetler LLP (Salix Pharmaceuticals, Inc.) |
| Document type | Other |
| Subtype | Partial Petition Approval and Denial |
| Agency | FDA |
| Docket | FDA-2016-P-3418 |
| Posted | Mar 16, 2017 |
| Comment period opens | Mar 16, 2017 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: